Safety Information: What Belongs in Your Conversation With a Provider Before You Start Do not use compounded GLP-1 medications if you have: a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
While the idea of administering a shot may seem intimidating, the process is simple, safe, and designed for ease
For obesity (Wegovy): AOM rider on the plan, BMI 30 or BMI 27 with at least one qualifying comorbidity, documentation of lifestyle modification counseling, and clinical narrative from the prescriber
This guide explains exactly what changed and what Washington state Aetna members need to know going into 2026
Comorbidities diabetes, heart disease, or fatty liver disease may influence drug choice
Emerging research on GLP-1 medications covers fatty liver, kidney disease, sleep apnoea, PCOS, and neurodegeneration